The high demand for immediate soluble tablets, rising prevalence of dysphagia, increase in usage of 3D printing, and the surge in adoption of personalized drugs propel the growth of the global 3D printed drugs.
The Global 3D Printed Drugs Market is estimated at $278 million in 2020 and is expected to reach $522 million by 2030, garnering a CAGR of 6.5% during the forecast period. The report offers a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.
The high demand for instantaneous soluble tablets, increasing prevalence of dysphagia, a surge in usage of 3D printing, and rising adoption of personalized drugs fuel the growth of the global 3D printed drugs. On the other hand, stringent government regulations for 3D printed products curb the growth to some extent. However, growing healthcare infrastructure, an increase in healthcare investment in emerging nations and raising awareness about 3D printing technology are expected to create multiple opportunities in the near future.
Download PDF Sample for More Statistical Data: https://www.alliedmarketresearch.com/request-sample/4508
The report segments the market into scenario and region. Based on scenario, the market is categorized into the Low Growth Scenario, Moderate Growth Scenario, and Rapid Growth Scenario. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Europe is expected to contribute to four-sevenths of the total market share in 2020 and is anticipated to retain its dominance throughout the forecast period. This is attributed to the presence of well-established healthcare systems and a surge in the incidence of dysphagia. Moreover, the rise in the acquisition of 3D printed drugs is projected to pave the way for a number of opportunities for the frontrunners in the European market. At the same time, the region across Asia-Pacific is expected to register the fastest growth rate during the estimated period. An increase in healthcare expenditure, surge in awareness related to 3D printing solutions, presence of a large patient pool, and high-end developments in healthcare infrastructure have triggered the adoption of 3D printed drugs in the region.
Check available discounts on this report at https://www.alliedmarketresearch.com/purchase-enquiry/4508
Leading market players-
The key players analyzed in the report include GlaxoSmithKline Plc., BV, Hewlett Packard Caribe, Aprecia Pharmaceuticals, FabRx Ltd., LLC, and 3D Printer Drug Machine. These players have incorporated different strategies including expansions, mergers & acquisitions, partnerships, joint ventures, collaborations, and others to heighten their stand in the market.
Scope of the Report:
|Market size available for years||2017 – 2030|
|Base year considered||2016|
|Forecast period||2017 – 2030|
|Forecast units||Value (USD)|
|Segments covered||By Spritam, by Scenario, and by Geography|
|Geographies covered||North America, Europe, Asia-Pacific, LAMEA|
3D Imaging Market by Product Type (3D Cameras, Sonography, Smart Phones, and Others), by Image Sensor (Charged Coupled Device and Complementary Metal-Oxide Semiconductors), by End-Use Industry (Entertainment, Healthcare, Architecture & Engineering, Industrial Applications, Security & Surveillance, and Others), by Application (3D Modelling, 3D Scanning, Layout & Animation, 3D Rendering, and Image Construction) – Global Opportunity Analysis and Industry Forecast, 2014-2022
Custom 3D Printed Implants Market by Product (Cranial Plates, and Hip Joints); Components (System/Devices, Materials, and Services) and by End Users (Medical and Surgical Centers, Pharma and Biotech Companies, and Academic Institutions) – Global Opportunity Analysis and Industry Forecast, 2019-2026
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research